Abbott Laboratories
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Abbott Laboratories (ABT) Annual Reports 10K
View all Abbott Laboratories 10-K annual reports filed with the SEC. Each report includes audited financial statements, revenue breakdown, risk factors, and Management’s Discussion & Analysis (MD&A). ...more
Abbott Laboratories Reports: Annual 10-K
SEC Filings
Date
2026
10-K
Annual financial results and management updates
2025
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2024
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2023
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2022
10-K
Annual financial results and management updates
2021
10-K
Annual financial results and management updates
2020
10-K
Annual financial results and management updates
2019
10-K
Annual financial results and management updates
2018
10-K
Annual financial results and management updates
2017
10-K
Annual financial results and management updates
2016
10-K
Annual financial results and management updates
2015
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2014
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2013
10-K/A
Amendment to a previously filed Annual Report
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2012
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2011
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2010
10-K
Annual financial results and management updates
2009
10-K
Annual financial results and management updates
2008
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2007
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2006
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2005
10-K
Annual financial results and management updates
2004
10-K
Annual financial results and management updates
2003
ARS
Annual Report to Shareholders
10-K
Annual financial results and management updates
2002
10-K405
Annual Report indicating disclosure of late insider filings under SEC rules
2001
10-K
Annual financial results and management updates
2000
10-K405
Annual Report indicating disclosure of late insider filings under SEC rules
Abbott Laboratories Annual Report (10-K) 2026
Annual Reports / Annual financial results and management updates
Feb 20, 2026
